Mesothelioma Cancer Resources Blog
- Mesothelioma Patients May Soon Receive Chemotherapy Via an Inhaler
Researchers at the University of Strathclyde in Glasgow, Scotland have devised a new delivery method for chemotherapy treatment for mesothelioma and lung cancer patients: using an inhaler instead of an IV needle. This latest discovery allows patients to inhale their cancer drugs through a nebulizer, allowing it to reach the diseased tissue more quickly and …
Label: Research News
Posted on Monday, Oct 17, 2011 - Mesothelioma Treatment May be Derived from Penn State Discovery
Researchers at the Penn State College of Medicine have filed for a U.S. patent on a significant discovery they made where a nondisease-causing virus was found to kill human breast cancer cells in the laboratory. The ability of adeno-associated virus type 2 (AAV2) to promote tumor cell death may result in new breakthrough cancer therapies …
Label: Research News
Posted on Friday, Oct 14, 2011 - UH Cancer Center Receives More Funds to Apply Towards Mesothelioma Research
One of the University of Hawaii Cancer Center’s leading mesothelioma researchers has received a $1.5 million grant from the National Cancer Institute. Haining Yang, PhD, who works with Michele Carbone, MD, PhD, the country’s premier authority on mesothelioma and director of the University of Hawaii Cancer Center, will use the five-year grant to “study the …
Label: Research News
Posted on Thursday, Oct 13, 2011 - Mesothelioma May Be Treated by Antibiotic in the Future
Antibiotics are used to treat infections caused by bacteria and are often prescribed for strep throat, sinus infections and pneumonia. Now, researchers at Van Andel Research Institute believe they are one step closer to using a particular antibiotic, geldanamycin, as an anti-cancer treatment. While much research still needs to be conducted, their findings may lead …
Label: Treatment News
Posted on Wednesday, Oct 12, 2011 - NORD Offers Support to the FDA to Provide Input for Drugs for Rare Diseases Such as Mesothelioma
The National Organization for Rare Disorders (NORD) is once again advocating for Americans with rare diseases by offering to provide input to the U.S. Food and Drug Administration on risk-benefit determination for new drugs and medical devices. NORD, and 30 of their advocacy partners, hope to offer a voice for patients with rare diseases such …
Label: Research News
Posted on Tuesday, Oct 11, 2011 - Long-Term Study of Workers Exposed to Asbestos Confirms High Cancer Risk, New York Mesothelioma Attorney Says
A newly released medical study underscores how asbestos exposure significantly increases the risk that workers will develop fatal lung cancers and other respiratory diseases, New York mesothelioma attorney Joseph W. Belluck said today. For 37 years, medical researchers at the Chinese University of Hong Kong tracked the health of 577 workers who were exposed to …
Label: Asbestos
Posted on Monday, Oct 10, 2011 - World Health Organization Reports Worldwide Deaths from Mesothelioma Have Risen Over the Last Fifteen Years
According to a comprehensive analysis of mesothelioma deaths reported worldwide between 1994 and 2008, the number of mesothelioma deaths, and the number of countries reporting deaths, increased during the study period. The authors of the study said the findings lead them to believe the mesothelioma burden is slowly shifting towards those countries that have used …
Label: Research News
Posted on Friday, Oct 7, 2011 - Oncologists Should Consider Starting Palliative Care at Mesothelioma Diagnosis, According to New Research
Mesothelioma, a rare cancer caused by asbestos exposure, is one of the most difficult cancers to treat due to its aggressiveness and resistance to standard cancer therapies. With no known cure for the disease, the treatments are often aimed at managing the symptoms and improving the patients’ quality of life. Once patients near their end …
Label: Treatment News
Posted on Thursday, Oct 6, 2011 - AACR Stresses Importance of Supporting Cancer Research for All Cancers, Including Mesothelioma and Other Rare Cancers
Cancer research requires significant amounts of time and money, and funding from the government, as well as private sources, is critical. Researchers seeking an effective treatment or cure for mesothelioma, a cancer caused by exposure to asbestos fibers, often receive funding through grants from the Mesothelioma Applied Research Foundation, the National Lung Cancer Partnership, the …
Label: For Your Family
Posted on Wednesday, Oct 5, 2011 - Pleural Mesothelioma Patients Praise Dr. Sugarbaker’s Treatment Approach for Their Happy, Full Lives
by Nancy Meredith Dr. David Sugarbaker has dedicated his career to treating malignant pleural mesothelioma, and for this, many patients say they owe their lives to him. Several of Sugarbaker’s former patients sat down with him earlier this year to discuss their battle with mesothelioma from diagnosis through their extended survival. Often called “asbestos cancer,” …
Label: Featured Story
Posted on Tuesday, Oct 4, 2011



